O’Reilly, C., Mills, S., Rea, M. C., Lavelle, A., Ghosh, S., Hill, C., & Ross, R. P. (2023). Interplay between inflammatory bowel disease therapeutics and the gut microbiome reveals opportunities for novel treatment approaches. Microbiome Res Rep.
Citação norma ChicagoO’Reilly, Catherine, Susan Mills, Mary C. Rea, Aonghus Lavelle, Subrata Ghosh, Colin Hill, and R. Paul Ross. "Interplay between Inflammatory Bowel Disease Therapeutics and the Gut Microbiome Reveals Opportunities for Novel Treatment Approaches." Microbiome Res Rep 2023.
MLA citiranjeO’Reilly, Catherine, et al. "Interplay between Inflammatory Bowel Disease Therapeutics and the Gut Microbiome Reveals Opportunities for Novel Treatment Approaches." Microbiome Res Rep 2023.
Opozorilo: Ti citati niso vedno 100% točni.